Omnicell (OMCL) Tops Q4 EPS by 18c

Omnicell (NASDAQ: OMCL) reported Q4 EPS of $0.33, $0.18 better than the analyst estimate of $0.15. Revenue for the quarter came in at $258.85 million versus the consensus estimate of $255.52 million.

For earnings history and earnings-related data on Omnicell (OMCL) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c